HPV E6-specific TCR-T cells / TCRCure - LARVOL DELTA

HPV-E6-Specific Anti-PD1 TCR-T Cells in the Treatment of HPV-Positive NHSCC or Cervical Cancer (clinicaltrials.gov) - P1 | N=9 | Completed | Sponsor: Xinqiao Hospital of Chongqing | Unknown status ➔ Completed | N=20 ➔ 9

Enrollment change • Trial completion • Cervical Cancer • Head and Neck Cancer • Oncology • Solid Tumor • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck

Newly added product - P2, HNSCC, Oncology

Pipeline update